1. Home
  2. FEMY vs CTRM Comparison

FEMY vs CTRM Comparison

Compare FEMY & CTRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • CTRM
  • Stock Information
  • Founded
  • FEMY 2004
  • CTRM 2016
  • Country
  • FEMY United States
  • CTRM Cyprus
  • Employees
  • FEMY N/A
  • CTRM N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • CTRM Marine Transportation
  • Sector
  • FEMY Health Care
  • CTRM Consumer Discretionary
  • Exchange
  • FEMY Nasdaq
  • CTRM Nasdaq
  • Market Cap
  • FEMY 12.5M
  • CTRM 21.2M
  • IPO Year
  • FEMY 2021
  • CTRM N/A
  • Fundamental
  • Price
  • FEMY $0.36
  • CTRM $2.09
  • Analyst Decision
  • FEMY Strong Buy
  • CTRM
  • Analyst Count
  • FEMY 3
  • CTRM 0
  • Target Price
  • FEMY $7.33
  • CTRM N/A
  • AVG Volume (30 Days)
  • FEMY 2.9M
  • CTRM 38.5K
  • Earning Date
  • FEMY 11-11-2025
  • CTRM 11-06-2025
  • Dividend Yield
  • FEMY N/A
  • CTRM N/A
  • EPS Growth
  • FEMY N/A
  • CTRM N/A
  • EPS
  • FEMY N/A
  • CTRM N/A
  • Revenue
  • FEMY $1,887,016.00
  • CTRM $66,197,291.00
  • Revenue This Year
  • FEMY $103.55
  • CTRM N/A
  • Revenue Next Year
  • FEMY $148.13
  • CTRM N/A
  • P/E Ratio
  • FEMY N/A
  • CTRM N/A
  • Revenue Growth
  • FEMY 98.61
  • CTRM N/A
  • 52 Week Low
  • FEMY $0.31
  • CTRM $1.91
  • 52 Week High
  • FEMY $1.80
  • CTRM $4.39
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 44.38
  • CTRM 44.72
  • Support Level
  • FEMY N/A
  • CTRM $1.97
  • Resistance Level
  • FEMY $0.40
  • CTRM $2.05
  • Average True Range (ATR)
  • FEMY 0.04
  • CTRM 0.07
  • MACD
  • FEMY -0.00
  • CTRM 0.00
  • Stochastic Oscillator
  • FEMY 64.19
  • CTRM 46.43

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About CTRM Castor Maritime Inc.

Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.

Share on Social Networks: